A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests
The drug Primodos and other hormone pregnancy tests (HPTs) remained on the British market for about a decade after they were first implicated, in 1967, as a possible cause of birth defects. In November 2017, an expert working group (EWG) set up by the Medicines and Healthcare Products Regulatory Age...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-08-01
|
| Series: | Reproductive Biomedicine & Society Online |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405661818300285 |